255 related articles for article (PubMed ID: 29730946)
41. Proton pump inhibitor associated hypomagnasaemia - a cause for concern?
Begley J; Smith T; Barnett K; Strike P; Azim A; Spake C; Richardson T
Br J Clin Pharmacol; 2016 Apr; 81(4):753-8. PubMed ID: 26613375
[TBL] [Abstract][Full Text] [Related]
42. Safety of long-term PPI use.
Med Lett Drugs Ther; 2017 Aug; 59(1527):131-133. PubMed ID: 28787743
[No Abstract] [Full Text] [Related]
43. [Long-term use of proton pump inhibitors--really harmless?].
Haag S
Dtsch Med Wochenschr; 2014 Feb; 139(7):343. PubMed ID: 24496898
[No Abstract] [Full Text] [Related]
44. [Long-term use of proton pump inhibitors--really harmless?].
Pommer P
Dtsch Med Wochenschr; 2014 Feb; 139(7):343. PubMed ID: 24496897
[No Abstract] [Full Text] [Related]
45. Proton Pump Inhibitors Should be Used with Caution in Critically Ill Patients to Prevent the Risk of Clostridium difficile Infection.
Min JH; Kim YS
Gut Liver; 2016 Jul; 10(4):493-4. PubMed ID: 27377737
[No Abstract] [Full Text] [Related]
46. [Long-term use of proton pump inhibitors--really harmless?].
Haag S
Dtsch Med Wochenschr; 2013 Nov; 138(45):2319-21. PubMed ID: 24163169
[No Abstract] [Full Text] [Related]
47. [Proton pump inhibitor - side effects and complications of long-term proton pump inhibitor administration].
Ueberschaer H; Allescher HD
Z Gastroenterol; 2017 Jan; 55(1):63-74. PubMed ID: 28073136
[TBL] [Abstract][Full Text] [Related]
48. Proton pump inhibitors: Understanding the associated risks and benefits of long-term use.
Thurber KM; Otto AO; Stricker SL
Am J Health Syst Pharm; 2023 Apr; 80(8):487-494. PubMed ID: 36629265
[TBL] [Abstract][Full Text] [Related]
49. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.
Howell MD; Novack V; Grgurich P; Soulliard D; Novack L; Pencina M; Talmor D
Arch Intern Med; 2010 May; 170(9):784-90. PubMed ID: 20458086
[TBL] [Abstract][Full Text] [Related]
50. What is the long term acid inhibitor treatment in gastroesophageal reflux disease? What are the potential problems related to long term acid inhibitor treatment in gastroesophageal reflux disease? How should these cases be followed?
Hatemi İ; Esatoğlu SN
Turk J Gastroenterol; 2017 Dec; 28(Suppl 1):S57-S60. PubMed ID: 29199170
[TBL] [Abstract][Full Text] [Related]
51. Reported proton pump inhibitor side effects: what are physician and patient perspectives and behaviour patterns?
Ghosh G; Schnoll-Sussman F; Mathews S; Katz PO
Aliment Pharmacol Ther; 2020 Jan; 51(1):121-128. PubMed ID: 31664732
[TBL] [Abstract][Full Text] [Related]
52. Clostridium difficile infection and proton pump inhibitors.
Pohl JF
Curr Opin Pediatr; 2012 Oct; 24(5):627-31. PubMed ID: 22781139
[TBL] [Abstract][Full Text] [Related]
53. Proton pump inhibitors and severe hypomagnesaemia.
Cundy T; Mackay J
Curr Opin Gastroenterol; 2011 Mar; 27(2):180-5. PubMed ID: 20856115
[TBL] [Abstract][Full Text] [Related]
54. Magnesium Deficiency and Proton-Pump Inhibitor Use: A Clinical Review.
William JH; Danziger J
J Clin Pharmacol; 2016 Jun; 56(6):660-8. PubMed ID: 26582556
[TBL] [Abstract][Full Text] [Related]
55. Indications and safety of proton pump inhibitor drug use in patients with cancer.
Triadafilopoulos G; Roorda AK; Akiyama J
Expert Opin Drug Saf; 2013 Sep; 12(5):659-72. PubMed ID: 23647006
[TBL] [Abstract][Full Text] [Related]
56. Short-term proton pump inhibitor treatment may cause hypomagnesaemia in critically ill patients - a pilot study.
Krzych ŁJ; Łój P; Nowak T; Kazura W; Knapik P
Acta Biochim Pol; 2017; 64(3):499-501. PubMed ID: 28651024
[TBL] [Abstract][Full Text] [Related]
57. Proton pump inhibitors, adverse events and increased risk of mortality.
Lanas-Gimeno A; Hijos G; Lanas Á
Expert Opin Drug Saf; 2019 Nov; 18(11):1043-1053. PubMed ID: 31498687
[No Abstract] [Full Text] [Related]
58. Reducing adverse effects of proton pump inhibitors.
Ament PW; Dicola DB; James ME
Am Fam Physician; 2012 Jul; 86(1):66-70. PubMed ID: 22962914
[TBL] [Abstract][Full Text] [Related]
59. Proton pump inhibitors and fractures? Beware long-term use.
Prescrire Int; 2009 Oct; 18(103):216. PubMed ID: 19885973
[No Abstract] [Full Text] [Related]
60. Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients.
Barletta JF; Sclar DA
Crit Care; 2014 Dec; 18(6):714. PubMed ID: 25540023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
